A group of experts who reviewed evidence on urinary tract infections (UTIs) failed to come up with many recommendations due ...

When we go to seek healthcare in hospitals or other healthcare settings, getting infected with hospital-acquired infections ...

The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

Despite the fact that sepsis causes an estimated 350,000 deaths in the U.S. each year, fewer than half of all Americans have ...

The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...

The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat certain types of bacterial ...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with ...

For children with a history of recurrent urinary tract infection (RUTI), nitrofurantoin and cranberry products may reduce the ...

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...

The FDA granted Priority Review to gepotidacin for the treatment of female adults and adolescents with uncomplicated UTI.

Recurrent urinary tract infections affect kidney function in children with vesicoureteral reflux. Antibiotics can protect ...